{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:05:11Z","timestamp":1792188311051,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.eprac.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T13:03:15Z","timestamp":1659790995000},"page":"1091-1099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Hypophosphatemia: A Practical Guide to Evaluation and Management"],"prefix":"10.1016","volume":"28","author":[{"given":"Peter J.","family":"Tebben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"31","key":"10.1016\/j.eprac.2022.07.005_bib1","first-page":"355","article-title":"Protein phosphorylation and metabolic control","author":"Krebs","year":"1975","journal-title":"Ciba Found Symp"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1146\/annurev.bi.48.070179.004423","article-title":"Phosphorylation-dephosphorylation of enzymes","volume":"48","author":"Krebs","year":"1979","journal-title":"Ann Rev Biochem"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.005_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archinte.1977.03630140051013","article-title":"The pathophysiology and clinical characteristics of severe hypophosphatemia","volume":"137","author":"Knochel","year":"1977","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0002-9343(82)90522-8","article-title":"Neuromuscular manifestations of electrolyte disorders","volume":"72","author":"Knochel","year":"1982","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/10408363.2017.1379945","article-title":"The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper","volume":"54","author":"Adeli","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00223-020-00686-3","article-title":"Phosphate metabolism in health and disease","volume":"108","author":"Peacock","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","article-title":"The phosphatonin pathway: new insights in phosphate homeostasis","volume":"65","author":"Schiavi","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ki.1985.93","article-title":"Effects of vitamin D on renal handling of calcium, magnesium and phosphate in the hamster","volume":"27","author":"Burnatowska","year":"1985","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib10","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4213","key":"10.1016\/j.eprac.2022.07.005_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1166316","article-title":"Parathyroid hormone and 25-hydroxy vitamin D3: synergistic and antagonistic effects on renal phosphate transport","volume":"190","author":"Puschett","year":"1975","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.005_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ackd.2011.01.005","article-title":"The regulation of renal phosphate transport","volume":"18","author":"Blaine","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00041552-199907000-00003","article-title":"Recent advances in epithelial sodium-coupled phosphate transport","volume":"8","author":"Tenenhouse","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.eprac.2022.07.005_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000346786","article-title":"Vitamin D and type II sodium-dependent phosphate cotransporters","volume":"180","author":"Kido","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.005_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.abb.2006.11.028","article-title":"Nuclear receptor 4A2 and C\/EBPbeta regulate the parathyroid hormone-mediated transcriptional regulation of the 25-hydroxyvitamin D3-1alpha-hydroxylase","volume":"460","author":"Zierold","year":"2007","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/abbi.2000.1970","article-title":"Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3","volume":"381","author":"Brenza","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.eprac.2022.07.005_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.005_bib18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0021-9258(18)33172-7","article-title":"Dietary phosphate deprivation increases 1,25-dihyroxyvitamin D3 synthesis in rat kidney in\u00a0vitro","volume":"258","author":"Gray","year":"1983","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.eprac.2022.07.005_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in\u00a0vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.eprac.2022.07.005_bib20","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.07310.x","article-title":"Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate","volume":"73","author":"Silver","year":"1999","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib21","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells","volume":"288","author":"Ito","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2022.07.005_bib22","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1359\/JBMR.050718","article-title":"Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D","volume":"20","author":"Collins","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib23","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2022.07.005_bib24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2215\/CJN.02680310","article-title":"Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23\/Klotho system","volume":"5","author":"Prie","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41430-020-00725-0","article-title":"The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials","volume":"75","author":"Zittermann","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.eprac.2022.07.005_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2020.00592","article-title":"Osteocytic FGF23 and its kidney function","volume":"11","author":"Agoro","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib27","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1\u03b1,25-dihydroxyvitamin D3 and phosphorus in\u00a0vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib28","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","article-title":"Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules","volume":"68","author":"Baum","year":"2005","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.eprac.2022.07.005_bib29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2012.07.002","article-title":"Fibroblast growth factor 23: state of the field and future directions","volume":"23","author":"Bhattacharyya","year":"2012","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2022.07.005_bib30","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","article-title":"Regulation and function of the FGF23\/klotho endocrine pathways","volume":"92","author":"Martin","year":"2012","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200001000-00001","article-title":"Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment","volume":"79","author":"Subramanian","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncpneph0124","article-title":"Hypophosphatemia: an evidence-based approach to its clinical consequences and management","volume":"2","author":"Amanzadeh","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/JSM.0b013e31820bcbe6","article-title":"Severe hypophosphatemia and acute neurologic dysfunction in a marathon runner","volume":"21","author":"Mohseni","year":"2011","journal-title":"Clin J Sport Med"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0016-5085(72)80032-5","article-title":"Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation","volume":"62","author":"Silvis","year":"1972","journal-title":"Gastroenterology"},{"issue":"8471","key":"10.1016\/j.eprac.2022.07.005_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(86)91926-4","article-title":"Acute severe hypophosphataemia mimicking Wernicke\u2019s encephalopathy","volume":"1","author":"Vanneste","year":"1986","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM198508153130705","article-title":"Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure","volume":"313","author":"Aubier","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2796.1989.tb00039.x","article-title":"Acute respiratory failure in anorexia nervosa with hypophosphataemia","volume":"225","author":"Gustavsson","year":"1989","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2044.1980.tb03718.x","article-title":"A\u00a0case of respiratory failure complicated by acute hypophosphataemia","volume":"35","author":"Brown","year":"1980","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","article-title":"FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets","volume":"22","author":"Imel","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.005_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder","volume":"82","author":"Econs","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib42","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A\u00a0clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis","year":"2010","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.eprac.2022.07.005_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000494726","article-title":"Prevalence of metabolic bone disease in tube-fed children receiving elemental formula","volume":"90","author":"Creo","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib46","first-page":"350","article-title":"Hypophosphatemia with muscle weakness due to antacids and hemodialysis","volume":"120","author":"Boelens","year":"1970","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.eprac.2022.07.005_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2017.02.003","article-title":"Unexpected widespread hypophosphatemia and bone disease associated with elemental formula use in infants and children","volume":"97","author":"Ballesteros","year":"2017","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.eprac.2022.07.005_bib48","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/0009922820941097","article-title":"Long-term follow-up of hypophosphatemic bone disease associated with elemental formula use: sustained correction of bone disease after formula change or phosphate supplementation","volume":"59","author":"Eswarakumar","year":"2020","journal-title":"Clin Pediatr (Phila)"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00254676","article-title":"Hypophosphatemia and acute respiratory failure in a diabetic patient","volume":"12","author":"Hasselstrom","year":"1986","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib50","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/eat.22406","article-title":"Predictors of hypophosphatemia during refeeding of patients with severe anorexia nervosa","volume":"48","author":"Brown","year":"2015","journal-title":"Int J Eat Disord"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.005_bib51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1258\/acb.2008.008199","article-title":"Hyperventilation and hypophosphataemia","volume":"46","author":"Datta","year":"2009","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib52","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/nqz037","article-title":"Vitamin D status in the United States, 2011-2014","volume":"110","author":"Herrick","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib54","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9-10","key":"10.1016\/j.eprac.2022.07.005_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000520299","article-title":"Variable clinical presentation of children with hereditary hypophosphatemic rickets with hypercalciuria: a case series and review of the literature","volume":"94","author":"Christensen","year":"2021","journal-title":"Horm Res Paediatr"},{"issue":"10","key":"10.1016\/j.eprac.2022.07.005_bib56","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","article-title":"Phosphaturic mesenchymal tumors: what an endocrinologist should know","volume":"41","author":"Boland","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.eprac.2022.07.005_bib57","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"suppl 4","key":"10.1016\/j.eprac.2022.07.005_bib58","first-page":"434","article-title":"Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23","volume":"4","author":"Imel","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00223-020-00692-5","article-title":"Congenital conditions of hypophosphatemia in children","volume":"108","author":"Imel","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib60","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jbmr.4558","article-title":"Osteomalacia as a complication of intravenous iron infusion: a systematic review of case reports","volume":"37","author":"Vilaca","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"issue":"11","key":"10.1016\/j.eprac.2022.07.005_bib61","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease","volume":"23","author":"Wolf","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"9","key":"10.1016\/j.eprac.2022.07.005_bib63","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/ndt\/gfx310","article-title":"A\u00a0controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy","volume":"33","author":"Huang","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.005_bib64","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.eprac.2022.07.005_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer","year":"2022","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.eprac.2022.07.005_bib66","doi-asserted-by":"crossref","first-page":"bvab099","DOI":"10.1210\/jendso\/bvab099","article-title":"Diagnosis and management of tumor-induced osteomalacia: perspectives from clinical experience","volume":"5","author":"Dahir","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib67","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jc.2011-1319","article-title":"Approach to the hypophosphatemic patient","volume":"97","author":"Imel","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2022.07.005_bib68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bone.2019.02.010","article-title":"Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: utility of the radiographic rickets severity score","volume":"122","author":"Thacher","year":"2019","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","article-title":"Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia","volume":"18","author":"Trombetti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib71","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/MNM.0000000000001379","article-title":"Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET\/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis","volume":"42","author":"Agrawal","year":"2021","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib72","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2796.2010.02262.x","article-title":"Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia","volume":"268","author":"Ito","year":"2010","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.005_bib73","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"11","key":"10.1016\/j.eprac.2022.07.005_bib74","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2013-2528","article-title":"Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy","volume":"98","author":"Tarasova","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-002018","article-title":"Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study","volume":"9","author":"van der Vaart","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0885066605275326","article-title":"Refeeding syndrome and hypophosphatemia","volume":"20","author":"Marinella","year":"2005","journal-title":"J\u00a0Intensive Care Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.005_bib77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0884533611427916","article-title":"Refeeding syndrome or refeeding hypophosphatemia: a systematic review of cases","volume":"27","author":"Skipper","year":"2012","journal-title":"Nutr Clin Pract"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.005_bib78","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jbmr.3992","article-title":"Hyperparathyroidism in patients with X-linked hypophosphatemia","volume":"35","author":"Lecoq","year":"2020","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.eprac.2022.07.005_bib79","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/js.2018-00338","article-title":"Nephrocalcinosis and nephrolithiasis in X-linked hypophosphatemic rickets: diagnostic imaging and risk factors","volume":"3","author":"Colares Neto","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"21","key":"10.1016\/j.eprac.2022.07.005_bib80","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.005_bib81","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A\u00a0randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib82","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10189","key":"10.1016\/j.eprac.2022.07.005_bib84","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.005_bib85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11914-021-00669-9","article-title":"Burosumab for pediatric X-linked hypophosphatemia","volume":"19","author":"Imel","year":"2021","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.005_bib86","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2200564X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2200564X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:13:10Z","timestamp":1761516790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2200564X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1530891X2200564X"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.07.005","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypophosphatemia: A Practical Guide to Evaluation and Management","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}